PT2405748T - Administração de ibuprofeno intravenoso - Google Patents

Administração de ibuprofeno intravenoso

Info

Publication number
PT2405748T
PT2405748T PT10751461T PT10751461T PT2405748T PT 2405748 T PT2405748 T PT 2405748T PT 10751461 T PT10751461 T PT 10751461T PT 10751461 T PT10751461 T PT 10751461T PT 2405748 T PT2405748 T PT 2405748T
Authority
PT
Portugal
Prior art keywords
ibuprophen
intravenous
administration
intravenous ibuprophen
Prior art date
Application number
PT10751461T
Other languages
English (en)
Inventor
Pavliv Leo
Original Assignee
Cumberland Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cumberland Pharmaceuticals Inc filed Critical Cumberland Pharmaceuticals Inc
Publication of PT2405748T publication Critical patent/PT2405748T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT10751461T 2009-03-12 2010-03-12 Administração de ibuprofeno intravenoso PT2405748T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15958509P 2009-03-12 2009-03-12

Publications (1)

Publication Number Publication Date
PT2405748T true PT2405748T (pt) 2018-11-23

Family

ID=42728808

Family Applications (2)

Application Number Title Priority Date Filing Date
PT10751461T PT2405748T (pt) 2009-03-12 2010-03-12 Administração de ibuprofeno intravenoso
PT181839291T PT3417708T (pt) 2009-03-12 2010-03-12 Administração de ibuprofeno intravenoso

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT181839291T PT3417708T (pt) 2009-03-12 2010-03-12 Administração de ibuprofeno intravenoso

Country Status (12)

Country Link
US (3) US9012508B2 (pt)
EP (2) EP3417708B1 (pt)
JP (1) JP2012523377A (pt)
KR (3) KR20140014350A (pt)
CN (1) CN102413687A (pt)
AU (1) AU2010224063B2 (pt)
BR (1) BRPI1006222A2 (pt)
CA (1) CA2754922C (pt)
DK (1) DK2405748T3 (pt)
ES (2) ES2823249T3 (pt)
PT (2) PT2405748T (pt)
WO (1) WO2010105129A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010224063B2 (en) 2009-03-12 2015-04-16 Cumberland Pharmaceuticals Inc Administration of intravenous ibuprofen
ES2742373T3 (es) * 2010-11-04 2020-02-14 Aft Pharmaceuticals Ltd Una composición de combinación
US20130190403A1 (en) * 2012-01-23 2013-07-25 Cumberland Pharmaceuticals Inc. Administration of intravenous ibuprofen to trauma patients
US9072661B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
US9072710B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
CN106999454A (zh) * 2014-10-06 2017-08-01 坎伯兰医药品股份有限公司 共同施用静脉内布洛芬和对乙酰氨基酚以治疗疼痛
SI3996699T1 (sl) 2019-07-09 2023-10-30 Farmalider, S. A. Kombinacija ibuprofena in tramadola za lajšanje bolečine

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1497044A (en) 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
DE2914788A1 (de) 1979-04-11 1980-10-16 Nattermann A & Cie Parenteral applizierbare, stabile arzneimittelloesungen mit entzuendungshemmender wirkung
US4587252A (en) 1984-12-18 1986-05-06 Brighton Pharmaceutical, Inc. Hydrocodone/ibuprofen pharmaceutical compositions and method
CH664085A5 (de) 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.
US4569937A (en) 1985-02-11 1986-02-11 E. I. Du Pont De Nemours And Company Analgesic mixture of oxycodone and ibuprofen
GB8521350D0 (en) 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
US4859704A (en) 1987-10-15 1989-08-22 Oratech Pharmaceutical Development Corporation Water soluble ibuprofen compositions and methods of making them
US4861797A (en) 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them
US5200558A (en) 1989-10-17 1993-04-06 Merck & Co., Inc. S(+)-ibuprofen-L-amino acid and S(+)-ibuprofen-D-amino acid as onset-hastened enhanced analgesics
TW225536B (pt) 1990-08-23 1994-06-21 Ciba Geigy Ag
IT1264857B1 (it) 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico
IT1266583B1 (it) 1993-07-30 1997-01-09 Zambon Spa Processo per la preparazione di sali dell'acido 2-(4-isobutilfenil)- propionico
US5840731A (en) * 1995-08-02 1998-11-24 Virginia Commonwealth University Pain-alleviating drug composition and method for alleviating pain
DE19912436A1 (de) * 1999-03-19 2000-09-21 Merckle Gmbh Ibuprofen-Lösung
US6423746B1 (en) 1999-07-03 2002-07-23 The William M. Yarbrough Foundation Urushiol induced contact dermatitis and method of use
US6342530B1 (en) 2000-11-14 2002-01-29 Farmacon-Il, Llc Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt
US20040132823A1 (en) 2001-11-02 2004-07-08 Leo Pavliv Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
US6727286B2 (en) 2001-11-02 2004-04-27 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
JP5185488B2 (ja) 2001-11-02 2013-04-17 カンバーランド ファーマシューティカルズ,インコーポレーテッド 2−(4−イソブチルフェニル)プロピオン酸の医薬組成物
EP1575584A4 (en) * 2002-11-29 2006-02-01 Forest Laboratories METHOD FOR THE TREATMENT OF ACUTE CHARACTERIZATION BY UNIFORM FORMING WITH IBUPROFEN AND OXYCODON
KR20050111598A (ko) * 2003-02-19 2005-11-25 리나트 뉴로사이언스 코퍼레이션 신경 성장 인자 길항제 및 nsaid를 투여함으로써통증을 치료하는 방법 및 그것을 함유하는 조성물
CN1871028A (zh) * 2003-02-19 2006-11-29 里纳特神经系统学公司 通过施用神经生长因子拮抗剂和nsaid和含有它们的组合物治疗疼痛的方法
US7151084B2 (en) 2004-12-27 2006-12-19 Miller Landon C G Compound and method of treating neurogenic conditions using non-steroidal anti-inflammatory drug complexes
BRPI0611170A2 (pt) * 2005-05-27 2010-08-17 Panacea Biotec Ltd composições injetáveis e processo para o preparo de tais composições
AR058071A1 (es) * 2005-10-03 2008-01-23 Astrazeneca Ab Derivados de dihidropirazolo (3,4-e)(1,4)diazepina. procesos de obtencion y composiciones farmaceuticas.
US7544676B2 (en) 2005-11-10 2009-06-09 Adolor Corporation Sulfamoyl benzamides and methods of their use
MX2010001789A (es) 2007-08-15 2010-03-10 Mcneil Ppc Inc Regimen de dosificacion de ibuprofeno de liberacion inmediata y liberacion sostenida.
WO2010006046A1 (en) 2008-07-10 2010-01-14 Tyrx Pharma, Inc. Nsaid delivery from polyarylates
AU2010224063B2 (en) 2009-03-12 2015-04-16 Cumberland Pharmaceuticals Inc Administration of intravenous ibuprofen
US8735452B2 (en) 2009-07-15 2014-05-27 Cumberland Pharmaceuticals Inc. Treating patients with intravenous ibuprofen
US8871810B2 (en) 2009-07-15 2014-10-28 Cumberland Pharmaceuticals Inc. Treating critically ill patients with intravenous ibuprofen
CN102625656A (zh) 2009-07-31 2012-08-01 坎伯兰医药品股份有限公司 用静脉内布洛芬治疗危重症患者

Also Published As

Publication number Publication date
ES2694506T3 (es) 2018-12-21
WO2010105129A1 (en) 2010-09-16
KR20170091775A (ko) 2017-08-09
KR101971412B1 (ko) 2019-04-22
KR20180063901A (ko) 2018-06-12
AU2010224063B2 (en) 2015-04-16
KR101864559B1 (ko) 2018-06-04
EP2405748B1 (en) 2018-08-15
EP2405748A1 (en) 2012-01-18
CA2754922C (en) 2016-10-18
CN102413687A (zh) 2012-04-11
ES2823249T3 (es) 2021-05-06
DK2405748T3 (en) 2018-12-03
EP2405748A4 (en) 2012-08-08
US9012508B2 (en) 2015-04-21
EP3417708A1 (en) 2018-12-26
PT3417708T (pt) 2020-10-12
US20150209315A1 (en) 2015-07-30
BRPI1006222A2 (pt) 2016-08-02
US20170281534A1 (en) 2017-10-05
JP2012523377A (ja) 2012-10-04
EP3417708B1 (en) 2020-06-17
KR20140014350A (ko) 2014-02-06
AU2010224063A1 (en) 2011-09-29
CA2754922A1 (en) 2010-09-16
US20100234465A1 (en) 2010-09-16

Similar Documents

Publication Publication Date Title
CY2020008I1 (el) Φαρμακοτεχνικες μορφες διστρωματικου δισκιου
EP2442821A4 (en) SAFE ADMINISTRATION OF DESMOPRESSIN
EP2549986A4 (en) MACROPHONE LEAVE TO MULTIPLE OBJECTIVES
DK2632493T3 (da) Lægemiddelindgivelsessammensætninger
IL245328A0 (en) Pharmaceutical composition
DK3603704T3 (da) Indgivelse af medikament
PT2405942T (pt) Produto de administração oral
EP2484393A4 (en) PRE-FILLED SYRINGE
BR112012011902A2 (pt) cápsula farmacêutica
EP3865162C0 (en) RINSE SYRINGE ASSEMBLY
EP2498844A4 (en) IMPFSPRITZE
EP2720699A4 (en) ADMINISTRATION OF BENZODIAZEPINE
EP2543405A4 (en) SYRINGE
EP2647707A4 (en) THERAPEUTICS WITH CYTOTOXICITY INDICATION
DK2506712T3 (da) Morfinanderivater til behandling af lægemiddeloverdosering
EP2560719A4 (en) LARYNX TUBE
EE201300005A (et) Ravimkoostis
DK3005986T3 (da) Infusion af lægemidler
BRPI1014688A2 (pt) aplicações terapêuticas de derivados de quinazolinadiona
SI2582366T1 (sl) Farmacevtska kombinacija za zdravljenje bolečine
UY33111A (es) Jeringas
BRPI0922653A2 (pt) preparação farmacêutica
PT2790693T (pt) Administração de estatinas sublinguais
BR112014004434A2 (pt) cateter biocompatível
EP2769718A4 (en) MEDICAL COMPOSITION